Vascular Health and Risk Management
Volume 11, 2015 - Issue
Open access
125
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
Samir Helmy Assaad-Khalil1 Department of Diabetology, Lipidology and Metabolism, Alexandria Faculty of Medicine, Alexandria University, Alexandria, EgyptCorrespondence[email protected]
, Robert Najem2 Lebanese University Hospital, Beirut, Lebanon
, Jorge Sison3 Medical Center Manila, Manila, Philippines
, Asad Riaz Kitchlew4 Pakistan Institute of Medical Sciences, Islamabad, Pakistan
, Belong Cho5 Seoul National University College of Medicine, Seoul, South Korea
, Kwo-Chang Ueng6 Chung Shan Medical University Hospital, Taichung City, Taiwan
, Shelley DiTommaso7 Novartis Pharma AG, Basel, Switzerland
& Abhijit Shete7 Novartis Pharma AG, Basel, Switzerland
show all
Pages 71-78
|
Published online: 21 Jan 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.